Clinical Trial Update: Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating short infusion versus prolonged infusion of ceftolozane-tazobactam for ventilator-associated pneumonia is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Zerbaxa (ceftolozane-tazobactam)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Ventilator-associated Pneumonia | Phase 3 | Status: RECRUITING